PNU-177864 hydrochloride
CAS No. 1783978-03-9
PNU-177864 hydrochloride( PNU-177864 (hydrochloride) )
Catalog No. M26387 CAS No. 1783978-03-9
PNU-177864 hydrochloride is a selective antagonist of D3 receptor with antischizophrenic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 41 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 25MG | 72 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePNU-177864 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionPNU-177864 hydrochloride is a selective antagonist of D3 receptor with antischizophrenic activity.
-
DescriptionPNU-177864 hydrochloride is a selective antagonist of D3 receptor with antischizophrenic activity.(In Vivo):In Sprague-Dawley rats, PNU-177864 hydrochloride (8-200 mg/kg; gavage) induces phospholipidosis in unusual target organs including epididymis, hair follicles and pituitary.
-
In Vitro——
-
In VivoPNU-177864 (12.5-200 mg/kg; oral gavage; daily; for 2-4 weeks; Sprague-Dawley rats) treatment induces phospholipidosis in unusual target organs in dogs or rats including epididymis, pituitary, and hair follicles. Animal Model:Male and female Sprague-Dawley rats (8-9-week-old)Dosage:12.5 mg/kg, 50 mg/kg (for 2 weeks), or 200 mg/kg; 8 mg/kg, 25 mg/kg, or 80 mg/kg (for 4 weeks)Administration:Oral gavage; daily; for 2-4 weeks Result:Induced phospholipidosis in unusual target organs in dogs or rats including epididymis, pituitary, and hair follicles.
-
SynonymsPNU-177864 (hydrochloride)
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorVHL
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1783978-03-9
-
Formula Weight438.89
-
Molecular FormulaC18H22ClF3N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.O=S(=O)(NC1=CC=C(C=C1)CCNCCC)C2=CC=C(OC(F)(F)F)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
-
5-HT6/7 antagonist 1
5-HT6/7 antagonist 1 is a dual 5-HT6/7/2A and D2 receptor antagonist used in the study of dementia and Alzheimer's disease.
-
ONC206
ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??
-
Fluphenazine hydroch...
Fluphenazine dihydrochloride is a phenothiazine-class D1DR and D2DR inhibitor.
Cart
sales@molnova.com